Comparability of European League Against Rheumatology-Recommended Pharmacological Treatments of Oral Ulcers Associated with Behçet’s Disease: A Systematic Literature Review of Randomized Controlled Trials
Tara Nazareth,1 Erin M Hart,2 Sarah M Ronnebaum,3 Sandhya Mehta,4 Dipen A Patel,3 Ina Kötter5 1Amgen Inc., Thousand Oaks, CA, USA; 2Pharmerit - an OPEN Health Company, New York, NY, USA; 3Pharmerit - an OPEN Health Company, Bethesda, MD, USA; 4Celgene Corporation, Summit, NJ, USA; 5Division...
Guardado en:
Autores principales: | Nazareth T, Hart EM, Ronnebaum SM, Mehta S, Patel DA, Kötter I |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8b05cfff646d4b0b851b08ff87385a91 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet’s Syndrome
por: Floris A, et al.
Publicado: (2019) -
Update on the diagnosis and management of Behçet’s disease
por: Rokutanda R, et al.
Publicado: (2014) -
Pattern of Uveitis Associated with Behçet’s Disease in an Egyptian Cohort
por: Abd El Latif E, et al.
Publicado: (2020) -
Recent Insights into the Management of Behçet Syndrome
por: Ozguler Y, et al.
Publicado: (2021) -
Behçet’s Disease in Children: Diagnostic and Management Challenges
por: Costagliola G, et al.
Publicado: (2020)